Skip to main content
logo
Evoke Pharma, Inc. (EVOK)
Dec 17, 2025 - EVOK was delisted (reason: acquired by QOL Medical)
11.00
+0.04 (0.36%)
Inactive · Last trade price on Dec 16, 2025

Evoke Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
249491868
Market Cap Growth
259.40%160.15%-60.81%-50.12%-73.62%73.44%
Enterprise Value
173321264
Last Close Price
11.004.4212.6032.1679.20371.52

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
2.120.890.683.5711.102957.72
PB Ratio
7.051.30-1.362.195.05-21.18
P/TBV Ratio
7.051.30-2.195.05-

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
1.200.270.490.707.342777.86

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
1.520.73-1.941.261.41-1.63
Asset Turnover
0.970.830.550.220.160.00
Inventory Turnover
0.790.770.521.561.56-
Quick Ratio
1.211.540.566.336.721.07
Current Ratio
1.271.660.717.097.511.23
Return on Equity (ROE)
-134.88%-240.09%-1035.44%-215.30%-5015.39%-2256.53%
Return on Assets (ROA)
-21.78%-26.46%-49.09%-43.40%-50.93%-103.03%
Return on Invested Capital (ROIC)
-36.33%-44.50%-79.84%-54.74%-96.14%-248.98%
Return on Capital Employed (ROCE)
-152.30%-72.90%288.10%-76.40%-88.90%-687.30%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-22.03%-58.59%-221.93%-91.79%-47.54%-19.32%
Buyback Yield / Dilution
-151.70%-583.90%-6.33%-17.21%-26.26%-14.34%
SEC Filings: 10-K · 10-Q